Requirement of Ras-dependent pathways for activation of the transforming growth factor β3 promoter by estradiol

Endocrinology

Volumn 142, Issue 2, 2001, Pages 751-759

  Lu, D ^a   Giguere V ^a  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN KINASE INHIBITOR; RAS PROTEIN; SERINE; TRANSFORMING GROWTH FACTOR BETA3;

ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE CONTROL; GENE DELETION; GENE INDUCTION; GENE MUTATION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; SIGNAL TRANSDUCTION;

EID: 0035105079     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.2.7937     Document Type: Article

References (41)

1. Estrogens
2. Sequence and expression of human estrogen receptor complementary DNA
3. Human oestrogen receptor cDNA: Sequence, expression and homology to v-ErbA
4. Cloning of a novel estrogen receptor expressed in rat prostate and ovary
5. ERβ: Identification and characterization of a novel human estrogen receptor
6. Cloning, chromosomal localization and functional analysis of the murine estrogen receptor β
7. Transcription activation by estrogen and progesterone receptors
8. Nuclear receptor coregulators: Cellular and molecular biology
9. The coregulator exchange in transcriptional functions of nuclear receptors
10. Activation of the ovalbumin gene by the estrogen receptor involves the Fos-Jun complex
11. Estrogen receptor-SP1 complexes mediate estrogen-induced cathepsin D gene expression in MCF-7 human breast cancer cells
12. A novel, cell-type-specific mechanism for estrogen receptor-mediated gene activation in the absence of an estrogen-responsive element
13. The estrogen receptor enhances AP-1 activity by two distinct mechanisms with different requirements for receptor transactivation functions
14. Ligand-independent activation of steroid hormone receptors
15. Stimulation of estrogen receptor-mediated transcription and alteration in the phosphorylation state of the rat uterine estrogen receptor by estrogen, cyclic adenosine monophosphate, and insulin-like growth factor-1
16. Modulation of transcriptional activation by ligand-dependent phosphorylation of the human oestrogen receptor A/B region
17. Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase
18. Activation of the unliganded estrogen receptor by EGF involves the MAP kinase pathway and direct phosphorylation
19. Ligand-independent recruitment of SRC-1 by estrogen receptor β through phosphorylation of activation function AF-1
20. Phosphorylation of the human estrogen receptor on tyrosine-537 in vivo by Src family tyrosine kinases in vitro
21. Regulation of estrogen receptor transcriptional enhancement by the cyclin A/Cdk2 complex
22. rsk1 regulates estrogen receptor-mediated transcription through phosphorylation of Ser-167
23. Phosphorylation of human estrogen receptor alpha by protein kinase A regulates dimerization
24. Potentiation of human estrogen receptor a transcriptional activation through phosphorylation of serines 104 and 106 by the cyclin A-CDK2 complex
25. Tamoxifen, raloxifene, and the prevention of breast cancer
26. Molecular basis of agonism and antagonism in the oestrogen receptor
27. The structural basis of estrogen receptor/coactivator recognition and the antagonism of this interaction by tamoxifen
28. Structure of the ligand-binding domain of oestrogen receptor β in the presence of a partial agonist and a full antagonist
29. Estrogen and raloxifene stimulate transforming growth factor-β3 gene expression in rat bone: A potential mechanism for estrogen- or raloxifene-mediated bone maintenance
30. Identification of an estrogen response element activated by metabolites of 17β-estradiol and raloxifene
31. Correction: Raloxifene response needs more than an element
32. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors
33. Identification of a novel isoform of the retinoic acid receptor γ expressed in the mouse embryo
34. EM-800, a novel antiestrogen, acts as a pure antagonist of the transcriptional functions of estrogen receptors α and β
35. Characterization of the effects of the novel non-steroidal antiestrogen EM-800 on basal and estrogen-induced proliferation of T47D, ZR-75-1 and MCF-7 human breast cancer cells in vitro
36. Skeletal effects of estrogen
37. Protein kinase C alpha activates RAF-1 by direct phosphorylation
38. The nuclear corepressors NCoR and SMRT are key regulators of both ligand- and 8-bromo-cyclic AMP-dependent transcriptional activity of the human progesterone receptor
39. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells
40. Different regions in activation function-1 of the human estrogen receptor required for antiestrogen- and estradiol-dependent transcription activation
41. Phosphorylation of steroid receptor coactivator-1. Identification of the phosphorylation sites and phosphorylation through the mitogen-activated protein kinase pathway